Clinical trials: People Who Infect Drugs (PWID)
HIV Positive People Who Inject Drugs
Rapid Antiretroviral Treatment Initiation With BIC/FTC/TAF in HIV-infected People Who Inject Drugs (PWID)
The goal of this clinical study is to evaluate the effectiveness, safety and patient experience of an integrated care pathway combining rapid antiretroviral (ART) initiation with BIC/FTC/TAF and peer navigation for treatment…
- Trial name
- BFTAFDU (NCT07004933)
- Testing
- bictegravir/emtricitabine/tenofovir alafenamide (BIC/F/TAF)
- Where
- 3 sites in Greece
- Volunteers
- 37 people
- Sponsor
- Hellenic Scientific Society for the Study of AIDS, Sexually Transmitted and Emerging Diseases
Drug Abuse, Intravenous
Case Management in HCV Infected PWID
To study the impact of case management on the outcome of the care of chronic hepatitis C in people who inject drugs (PWID). By creating the function of case manager, the investigators will target all the barriers to care of the…
- Trial name
- CM-HCV (NCT03106194)
- Testing
- case management
- Where
- Belgium
- Volunteers
- 441 people
- Sponsor
- Hasselt University
Hepatitis C, HIV Coinfection
Supporting Treatment Outcomes Among PWID
The goal of this study is to improve HCV care continuum outcomes for people who inject drugs (PWID), reduce potential onward transmission to others and improve HIV outcomes among those who are HIV/HCV coinfected.
- Trial name
- STOP-C (NCT04652804)
- Testing
- Low intensity HCV treatment adherence support, Medium intensity HCV treatment adherence support, High intensity HCV treatment adherence support
- Where
- India
- Volunteers
- 3,000 people
- Sponsor
- Johns Hopkins University
Peer Support, Injection-related Infections
The Injection-Related InfectionS (IRIS) Program
People who inject drugs are at risk of injection-related infections, like abscesses or infective endocarditis. The Injection-Related InfectionS (IRIS) program hopes to improve treatment for participants by providing a…
- Conditions
- Peer Support, Injection-related Infections, Infections, People Who Infect Drugs (PWID)
- Trial name
- IRIS (NCT06169553)
- Testing
- Holistic injection-related injection treatment
- Where
- 2 sites in Canada
- Volunteers
- 80 people
- Sponsor
- McMaster University